Cell and Gene Outsourcing

  1. Confirming Feeder Cells For TIL Expansion 5/28/2025

    To ensure the safety of tumor-infiltrating leukocytes (TIL) therapies, it's important to use cGMP-compliant feeder cells confirmed to be non-proliferative through competency testing.

  2. Spotlight On Excell-Ence: Quality Assurance Team 5/28/2025

    A QA team at a cell therapy CDMO ensures all aspects of development and manufacturing meet the highest standards of quality, safety, and regulatory compliance.

  3. Cell Therapy Services: Customized Cell Collections 5/28/2025

    Ready to go deeper on cell characterization? Advance past typical cell and donor screening to create a comprehensive immune cell profile for each donor as well as an assessment of the metabolic and effector potential of their cells. See beyond surface markers too.

  4. Cell Therapy Services: Process Development And cGMP Manufacturing 5/28/2025

    Now that you have the best donated cellular material, it is time to optimize your cell therapy process for cGMP manufacturing. We offer R&D services including process development and cGMP production for Phase I through Commercial manufacturing.

  5. The Power Of Partnerships And The Rise Of iPSC 5/23/2025

    During the Cell & Gene Live, Unlocking the Potential of iPSC Therapies in Regenerative Medicine, Julie Allickson, Ph.D., Chief Technology Officer at Mayo Clinic's Center for Regenerative Biotherapeutics and Erin Kimbrel, Ph.D., Head of Cell & Gene Therapy Research at Astellas emphasize that partnerships and collaboration are essential to advancing regenerative medicine and iPSC-based therapies.

  6. Mastering The Complexities Of Gene Therapy Document Writing 5/20/2025

    Gain the insight and strategic flexibility needed to confidently navigate the unique scientific, regulatory, and documentation challenges of gene therapy development.

  7. Biomanufacturing Operator Training And Solutions 5/20/2025

    Discover a hands-on biomanufacturing training program that empowers operators with essential skills, boosts efficiency, and supports innovation in the fast-paced biopharma industry.

  8. Lock Into Your Go-To Data Strategy 5/16/2025

    Explore data solutions for every clinical study - whether you are engaging our comprehensive CRO services or require specific, functional solutions to support your project.

  9. How To Think About Valuation In Biotech 5/16/2025

    Frank David, Founder and Managing Director of Pharmagellan, discusses how mission, vision, and data analysis fit into today's biotech goals.

  10. Working With An End-To-End CDMO To De-Risk AAV Production 5/15/2025

    Consider how the following strategies can be used to optimize AAV manufacturing by reducing risk and balancing productivity, quality, and cost to meet the growing demands of gene therapy.